ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Carroll Named Deputy Director At Huntsman; Pamer Leads Infectious Disease Service, MSKCC.

September 29, 2000

DCBDC board Okays RFA concept On AIDS Lymphoma

March 26, 1993

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981

In Brief: Accidents Claim Wisconsin’s William Caldwell, John Wear; Murchison, Nance To Head Nalsi

June 15, 1979

Consensus Conference Planned On Adjuvant Chemotherapy For Breast Cancer

March 22, 1985

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012